W.H.O IN TALKS WITH PFIZER, MODERNA ON COVID-19 VACCINE ACCESS
The World Health Organization (WHO) said Tuesday it is in discussions with Pfizer and Moderna about possibly including their high-tech coronavirus vaccines among early jabs for poor countries at affordable prices.
The WHO-backed Covax facility, created to ensure equitable access to coronavirus disease 2019 (COVID-19) vaccines around the world as they become available, is aiming to provide some two billion doses by the end of next year.
It has already secured hundreds of millions of doses of vaccine candidates being developed by AstraZeneca, Novavax and Sanofi-GSK.
WHO senior advisor Bruce Aylward said the organization was looking at a range of other jabs, as well as the current frontrunners.